孕酮通过Rho激酶-Cofilin轴驱动子宫内膜蜕膜化
该研究结合聚焦激酶活性检测与大规模蛋白质组学,在体外和体内子宫内膜蜕膜化中鉴定Rho激酶(ROCK)及其下游Cofilin-1(CFL1)的作用。体外孕酮联合8-Br-cAMP处理使ROCK活性升高,分泌期子宫内膜中ROCK2 mRNA和蛋白及磷酸化CFL1增加,而多囊卵巢综合征(PCOS)患者来源细胞反应减弱。
要点
- 孕酮联合cAMP诱导体外蜕膜化中ROCK活性升高,且孕酮对ROCK激活是必需的。
- 分泌期子宫内膜较增殖期ROCK活性升高,磷酸化CFL1增加,PCOS患者此反应减弱。
- ROCK2下游信号改变细胞骨架,体外蜕膜化子宫内膜基质细胞迁移能力显著下降。
核心结论
- 孕酮通过激活ROCK-Cofilin轴参与子宫内膜蜕膜化,PCOS患者该轴反应减弱。
研究设计与样本
- 体外研究使用对照组(N=15)和PCOS患者(N=9)的第2代子宫内膜基质细胞(ESC)。
- 非培养ESC来自增殖期(N=4)和分泌期(N=4)子宫内膜组织,并行蛋白质组和磷酸化蛋白质组研究。
- 趋势验证使用增殖期(N=3)和分泌期(N=3)冰冻切片,以及对照组(增殖期N=8、分泌期N=9)和PCOS患者(两期各N=10)全组织样本。
主要发现
- 体外蜕膜化4天时PKA、Akt/PKB和ROCK活性升高、CK2活性降低(P<0.05),9天时进一步加剧(P<0.001)。
- 分泌期较增殖期非培养ESC仅ROCK活性升高(P<0.01)。
- 对照组分泌期全组织ROCK2 mRNA高于增殖期(P<0.05),PCOS患者无此差异。
- 对照组分泌期子宫内膜和体外蜕膜化ESC中磷酸化S3 CFL1增加(分别P<0.001和P<0.01),PCOS患者无此增加。
- 体外蜕膜化ESC迁移能力显著下降(P<0.05)。
关键数值与推荐
- 孕酮存在是ROCK激活的必要条件,而PKA和Akt/PKB激活不依赖孕酮。
- PCOS患者来源ESC对孕酮反应减弱。
临床怎么用
- ROCK-Cofilin轴可作为蜕膜化相关不孕和生育力低下研究的候选靶点。
- PCOS患者子宫内膜蜕膜化中孕酮反应减弱,提示需关注该人群的蜕膜化异常。
局限性
- 生物样本数量有限。
- 非培养ESC分离流程时长可能影响细胞磷酸化通路,但增殖期和分泌期样本处理一致以减少伪影。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can a combination of the focussed protein kinase assays and a wide-scale proteomic screen pinpoint novel, clinically relevant players in decidualization in vitro and in vivo? SUMMARY ANSWER: Rho-dependent protein kinase (ROCK) activity is elevated in response to the combined treatment with progesterone and 8-Br-cAMP during in vitro decidualization, mirrored by increase of ROCK2 mRNA and protein levels and the phosphorylation levels of its downstream target Cofilin-1 (CFL1) in secretory versus proliferative endometrium. WHAT IS KNOWN ALREADY: Decidualization is associated with extensive changes in gene expression profile, proliferation, metabolism and morphology of endometrium, yet only a few underlying molecular pathways have been systematically explored. In vitro decidualization of endometrial stromal cells (ESCs) can be reportedly induced using multiple protocols with variable physiological relevance. In our previous studies, cyclic AMP (cAMP)/cAMP-dependent protein kinase (PKA)/prolactin axis that is classically upregulated during decidualization showed dampened activation in ESCs isolated from polycystic ovary syndrome (PCOS) patients as compared to controls. STUDY DESIGN, SIZE, DURATION: In vitro decidualization studies were carried out in passage 2 ESCs isolated from controls (N = 15) and PCOS patients (N = 9). In parallel, lysates of non-cultured ESCs isolated from proliferative (N = 4) or secretory (N = 4) endometrial tissue were explored. The observed trends were confirmed using cryo-cut samples of proliferative (N = 3) or secretory endometrium (N = 3), and in proliferative or secretory full tissue samples from controls (N = 8 and N = 9, respectively) or PCOS patients (N = 10 for both phases). PARTICIPANTS/MATERIALS, SETTING, METHODS: The activities of four target kinases were explored using kinase-responsive probes and selective inhibitors in lysates of in vitro decidualized ESCs and non-cultured ESCs isolated from tissue at different phases of the menstrual cycle. In the latter lysates, wide-scale proteomic and phosphoproteomic studies were further carried out. ROCK2 mRNA expression was explored in full tissue samples from controls or PCOS patients. The immunofluorescent staining of phosphorylated CFL1 was performed in full endometrial tissue samples, and in the in vitro decidualized fixed ESCs from controls or PCOS patients. Finally, the cellular migration properties were explored in live in vitro decidualized ESCs. MAIN RESULTS AND THE ROLE OF CHANCE: During in vitro decidualization, the activities of PKA, protein kinase B (Akt/PKB), and ROCK are increased while the activity of casein kinase 2 (CK2) is decreased; these initial trends are observable after 4-day treatment (P < 0.05) and are further augmented following the 9-day treatment (P < 0.001) with mixtures containing progesterone and 8-Br-cAMP or forskolin. The presence of progesterone is necessary for activation of ROCK, yet it is dispensable in the case of PKA and Akt/PKB; in comparison to controls, PCOS patient-derived ESCs feature dampened response to progesterone. In non-cultured ESCs isolated from secretory vs proliferative phase tissue, only activity of ROCK is increased (P < 0.01). ROCK2 protein levels are slightly elevated in secretory versus proliferative ESCs (relative mean standard deviation < 50%), and ROCK2 mRNA is elevated in mid-secretory versus proliferative full tissue samples (P < 0.05) obtained from controls but not PCOS patients. Activation of ROCK2 downstream signalling results in increase of phospho-S3 CFL1 in secretory endometrium (P < 0.001) as well as in vitro decidualized ESCs (P < 0.01) from controls but not PCOS patients. ROCK2-triggered alterations in the cytoskeleton are reflected by the significantly decreased motility of in vitro decidualized ESCs (P < 0.05). LARGE SCALE DATA: Proteomic and phosphoproteomic data are available via ProteomeXchange with identifier PXD026243. LIMITATIONS, REASONS FOR CAUTION: The number of biological samples was limited. The duration of protocol for isolation of non-cultured ESCs from tissue can potentially affect phosphorylation pathways in cells, yet the possible artefacts were minimized by the identical treatment of proliferative and secretory samples. WIDER IMPLICATIONS OF THE FINDINGS: The study demonstrated the benefits of combining the focussed kinase activity assay with wide-scale phosphoproteomics and showed the need for detailed elaboration of the in vitro decidualization protocols. ROCK was identified as the novel target of interest in decidualization, which requires closer attention in further studies-including the context of decidualization-related subfertility and infertility. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the Estonian Ministry of Education and Research, and the Estonian Research Council (PRG1076, PRG454, PSG230 and PSG608), Enterprise Estonia (EU48695), Horizon 2020 innovation grant (ERIN, Grant no. EU952516) of the European Commission, the COMBIVET ERA Chair, H2020-WIDESPREAD-2018-04 (Grant agreement no. 857418), the Academy of Finland (Project grants 315921 and 321763), the Finnish Medical Foundation and The Sigrid Juselius Foundation. The authors confirm that they have no conflict of interest with respect to the content of this article.
引用
- Lavogina D, Stepanjuk A, Peters M, et al. Progesterone triggers Rho kinase-cofilin axis during in vitro and in vivo endometrial decidualization. Hum Reprod. 2021. PMID: 34270712. doi:10.1093/humrep/deab161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。